Physician profile
Rosa Lees
NPI 1245213669
$2,845.51
in general payments reported to CMS, 2019-2025
14 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $919 · 2022: $604 · 2023: $317 · 2024: $702 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,321.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,331.31 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $323.95 | 2021-2025 | Lifevest |
| Novo Nordisk INC | $245.58 | 2022-2024 | Wegovy |
| Abbvie INC. | $159.08 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.79 | 2022 | |
| Phathom Pharmaceuticals, INC. | $122.79 | 2024 | Voquezna |
| Edwards Lifesciences Corporation | $122.18 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Astrazeneca Pharmaceuticals LP | $100.52 | 2024 | Airsupra |
| Smith+Nephew, INC. | $97.74 | 2021 | |
| Medtronic, INC. | $87.82 | 2023 | Interstim |
| Biohaven Pharmaceuticals, INC. | $41.09 | 2021 | |
| Boston Scientific Corporation | $35.78 | 2024 | Watchman Access System |
| Stryker Corporation | $34.22 | 2024 | Scopis Ent |
| Novartis Pharmaceuticals Corporation | $20.66 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rosa Lees listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.